It may have not been the record-breaking campaign that it looked on pace to be early in the season, but JSN locked in one ...
Former USC quarterback Sam Darnold’s redemption story has been exciting for NFL fans to watch over the past two seasons. After last season’s tremendous run with ...
The Seattle Seahawks are feeling themselves after clinching the No. 1 seed in the NFC, and star receiver Jaxon Smith-Njigba ...
While his stats weren’t spectacular, quarterback Sam Darnold had a big hand in the Seahawks’ 13-3 win over the 49ers that ...
Embattled QB comes up big – along with supporting cast – as Seattle nails down the No. 1 seed with resounding smackdown at ...
Seattle Seahawks quarterback Sam Darnold hits wide receiver Jaxon Smith-Njigba for an 18-yard gain in Week 18 against the San ...
Jaxon Smith-Njigba got a major boost from the San Francisco 49ers' plan to cover the Seattle Seahawks star wide receiver in ...
The Seahawks will have six players represented at the 2026 Pro Bowl Games, with a mix of first-time selections and familiar ...
Investing.com - Vir Biotechnology (NASDAQ:VIR) shares are likely to trade higher after the company announced a commercialization partnership with European specialty pharmaceutical company Norgine for ...
Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine in a licensing deal that’s worth up to 550 million euros ($645 million) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results